Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
75182913	7518291	3	F	20100226	20160823	20100802	20160823	EXP		US-BRISTOL-MYERS SQUIBB COMPANY-14960710	BRISTOL MYERS SQUIBB		29.16	YR		F	Y	0.00000		20160823		CN	US	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
75182913	7518291	1	PS	ABILIFY	ARIPIPRAZOLE	1	Oral	15 MG, QD	3375	MG	Y				21436	15	MG	TABLET	QD
75182913	7518291	2	SS	TRILEPTAL	OXCARBAZEPINE	1	Oral	600 MG, QD	135000	MG	Y				0	600	MG		QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
75182913	7518291	1	Bipolar disorder
75182913	7518291	2	Bipolar disorder

Outcome of event

Event ID	CASEID	OUTC COD
75182913	7518291	OT

Reactions reported

Event ID	CASEID	PT
75182913	7518291	Caesarean section
75182913	7518291	Live birth
75182913	7518291	Maternal exposure during pregnancy
75182913	7518291	Twin pregnancy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
75182913	7518291	1	20090717	20100226	0
75182913	7518291	2	20090717	20100226	0